Patient-related post-ERCP pancreatitis (PEP) risk factors between two groups of patients: Prophylactic pancreatic stent and rectal indomethacin

Patient-related post-ERCP pancreatitis (PEP) risk factors between two groups of patients: Prophylactic pancreatic stent and rectal indomethacin

Background: Pancreatitis is one of the most crucial complications following endoscopic retrograde cholangiopancreatography (ERCP). The purpose of the current study was to investigate patient-related post-ERCP pancreatitis (PEP) risk factors in two groups of patients: prophylactic pancreatic stent an...

Full description

Bibliographic Details
Main Authors: Hossein Ghalehnoei, Ahmad Hormati, Amir Houshang Mohammad Alizadeh, Sajjad Ahmadpour, Seyed Hassan Abedi
Format: Article
Language:English
Published: Babol University of Medical Sciences 2022-09-01
Series:Caspian Journal of Internal Medicine
Subjects:
ercp
post ercp pancreatitis
pancreatic duct stent
rectal indomethacin
Online Access:http://caspjim.com/article-1-3033-en.html

Internet

http://caspjim.com/article-1-3033-en.html

Similar Items